Companies: 10,795·Total market cap: $144.5T
Akoya Biosciences, Inc.

Akoya Biosciences, Inc.

AKYANASDAQHealthcare
$1.29
$-0.07(-5.15%)
Market Cap$64440918
P/E Ratio
52W High$3.42
52W Low$0.931

Akoya Biosciences, Inc. (AKYA) Revenue

Annual & quarterly revenue history · segment & region breakdown

AKYA · revenue · updated Jun 9, 2026

Core revenue metrics

Akoya Biosciences, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
205 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Akoya Biosciences, Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
AKYA revenue by year · AKYA revenue history · AKYA annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Akoya Biosciences, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Akoya Biosciences, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Akoya Biosciences, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

AKYA revenue · 4 questions

AKYA's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

AKYA revenueAKYA annual revenuewhat is AKYA revenueAKYA TTM revenue

Source: FMP · Akoya Biosciences, Inc. SEC filings · GAAP · Akoya Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026